IDEXX Laboratories Inc (IDXX)
539.63
+9.03
(+1.70%)
USD |
NASDAQ |
Mar 27, 16:00
540.00
+0.37
(+0.07%)
After-Hours: 04:27
IDEXX Laboratories Cash from Investing (TTM): -125.25M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -125.25M |
September 30, 2023 | -144.05M |
June 30, 2023 | -165.41M |
March 31, 2023 | -193.02M |
December 31, 2022 | -195.35M |
September 30, 2022 | -190.16M |
June 30, 2022 | -190.64M |
March 31, 2022 | -310.22M |
December 31, 2021 | -292.97M |
September 30, 2021 | -264.62M |
June 30, 2021 | -234.40M |
March 31, 2021 | -84.29M |
December 31, 2020 | -109.38M |
September 30, 2020 | -189.60M |
June 30, 2020 | -207.46M |
March 31, 2020 | -216.99M |
December 31, 2019 | -205.53M |
September 30, 2019 | -149.46M |
June 30, 2019 | -166.35M |
March 31, 2019 | -159.92M |
December 31, 2018 | 138.60M |
September 30, 2018 | 153.96M |
June 30, 2018 | 166.69M |
March 31, 2018 | 150.64M |
December 31, 2017 | -138.69M |
Date | Value |
---|---|
September 30, 2017 | -128.48M |
June 30, 2017 | -109.94M |
March 31, 2017 | -96.00M |
December 31, 2016 | -90.79M |
September 30, 2016 | -102.52M |
June 30, 2016 | -134.38M |
March 31, 2016 | -171.58M |
December 31, 2015 | -308.41M |
September 30, 2015 | -318.01M |
June 30, 2015 | -286.65M |
March 31, 2015 | -228.40M |
December 31, 2014 | -80.41M |
September 30, 2014 | -61.77M |
June 30, 2014 | -64.06M |
March 31, 2014 | -81.40M |
December 31, 2013 | -86.06M |
September 30, 2013 | -86.13M |
June 30, 2013 | -79.32M |
March 31, 2013 | -68.08M |
December 31, 2012 | -58.13M |
September 30, 2012 | -95.99M |
June 30, 2012 | -93.41M |
March 31, 2012 | -95.06M |
December 31, 2011 | -94.21M |
September 30, 2011 | -53.69M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-310.22M
Minimum
Mar 2022
-84.29M
Maximum
Mar 2021
-189.75M
Average
-190.40M
Median
Cash from Investing (TTM) Benchmarks
Haemonetics Corp | -327.34M |
Stryker Corp | -962.00M |
Align Technology Inc | -195.94M |
Edwards Lifesciences Corp | 173.80M |
Insulet Corp | -119.40M |